Quote:
Originally Posted by musicman48 Robert,I have'nt talked about this here but....I also daytrade stocks as a hobby.Titan Pharms stock bottomed out..No one has much faith in Titan Pharms longevity.Their stock is trading at 3 cents a share down from 1.65 a share 1 year ago. They were delisted from the AMEX and are now a pink sheet stock.Thats bad.Things do not look good for them...You never know though They may turn things around.I have seen it before.If so,now would be a great time to buy some of their penny stocks.This is their latest press release from last months investor relations.Hope you are doing well! http://phx.corporate-ir.net/phoenix....cle&ID=1235948 |
musicman .... I know what you mean about Titan as I'm a retired financial advisor. They are not quite a Pfizer or Merck.

But I will make a suggestion as this is why I was asking about the probuphine approval. If they do get FDA approval for this new buprenorphine drug implant it could be a huge shot in the arm for them financially.
I think Titan might be worth considering if you look at the links on my previous post in this thread. The stage III clinical trials look very good. They are at the stage where the approval stage is not that far away if it's going to happen.
Not saying it would make them the next Merck but it could definitely take their stock value up a few bucks a share in my opinion. It's something you might want to think about, at least watch what this new drug does. Just my observation, I've been known to pick a few winners over the years. God bless.